Literature DB >> 6331435

Prolactin receptors on human lymphocytes and their modulation by cyclosporine.

D H Russell, L Matrisian, R Kibler, D F Larson, B Poulos, B E Magun.   

Abstract

Prolactin receptors have been identified for the first time on human peripheral blood lymphocytes. These receptors are present on T- and B-cells as well as monocytes. The specific binding of [125I]prolactin to these cells can be selectively enhanced at certain concentrations and blocked by higher concentrations of cyclosporine , a known immunosuppressive agent which inhibits the mitogenesis of T-cells. Prolactin also induces ornithine decarboxylase, a key growth regulatory enzyme, in lymphocytes. Therefore, we suggest that the lymphocyte prolactin receptor may be involved in regulating lymphocyte function, and that one of the actions of cyclosporine is to block this rather ubiquitously occurring receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331435     DOI: 10.1016/0006-291x(84)90762-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  The role of prolactin in the pathogenesis of autoimmune disease.

Authors:  Istvan Berczi
Journal:  Endocr Pathol       Date:  1993-12       Impact factor: 3.943

2.  Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes.

Authors:  J F Gauchat; E W Khandjian; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Bromocriptine restores tolerance in estrogen-treated mice.

Authors:  E Peeva; C Grimaldi; L Spatz; B Diamond
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

4.  The effects of co-dergocrine on cyclosporin A pharmacokinetics and pharmacodynamics.

Authors:  D A Heinrichs; R Martell; C R Stiller; D Freeman; G Carruthers
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

5.  GH3 pituitary adenoma cells can reverse thymic aging in rats.

Authors:  K W Kelley; S Brief; H J Westly; J Novakofski; P J Bechtel; J Simon; E B Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice.

Authors:  D H Russell; K T Mills; F J Talamantes; H A Bern
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro.

Authors:  K Morkawa; F Oseko; S Morikawa
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Prolactin modulates the naive B cell repertoire.

Authors:  Elena Peeva; Daniel Michael; James Cleary; Jeffrey Rice; Xian Chen; Betty Diamond
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

9.  50 kD prolactin binding protein in schizophrenics on neuroleptic medication.

Authors:  A M Walker; C A Peabody; T W Ho; M D Warner
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

10.  Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen.

Authors:  A R Buckley; P D Crowe; D H Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.